GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optus Pharmaceutical Co Ltd (XKRX:131030) » Definitions » Cyclically Adjusted PS Ratio

Optus Pharmaceutical Co (XKRX:131030) Cyclically Adjusted PS Ratio : 2.03 (As of Jun. 19, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Optus Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-06-19), Optus Pharmaceutical Co's current share price is ₩7550.00. Optus Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩3,713.36. Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 2.03.

The historical rank and industry rank for Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:131030' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.31   Med: 1.85   Max: 2.76
Current: 1.64

During the past years, Optus Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 2.76. The lowest was 1.31. And the median was 1.85.

XKRX:131030's Cyclically Adjusted PS Ratio is ranked better than
58.82% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs XKRX:131030: 1.64

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Optus Pharmaceutical Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ₩1,220.392. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩3,713.36 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Optus Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optus Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Optus Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.70 2.08 1.82 1.46

Optus Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.79 1.59 1.38 1.46 1.89

Competitive Comparison of Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Optus Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=7550.00/3713.36
=2.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optus Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Optus Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1220.392/118.8477*118.8477
=1,220.392

Current CPI (Mar. 2024) = 118.8477.

Optus Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 504.864 99.353 603.927
201409 528.299 99.608 630.342
201412 557.690 99.098 668.835
201503 499.393 99.720 595.184
201506 591.194 100.050 702.269
201509 679.940 100.110 807.205
201512 592.132 100.220 702.190
201603 602.313 100.560 711.849
201606 671.789 100.790 792.148
201609 720.998 101.460 844.559
201612 743.524 101.560 870.088
201703 763.332 102.850 882.064
201706 759.044 102.610 879.160
201709 817.704 103.490 939.050
201712 714.501 102.990 824.515
201803 771.741 104.100 881.072
201806 792.906 104.130 904.975
201809 772.913 105.650 869.465
201812 703.639 104.350 801.398
201903 879.601 104.490 1,000.465
201906 926.903 104.880 1,050.346
201909 884.016 105.200 998.700
201912 1,011.516 105.120 1,143.611
202003 968.295 105.540 1,090.389
202006 1,113.821 104.870 1,262.278
202009 1,007.367 106.200 1,127.338
202012 686.263 105.765 771.148
202103 895.500 107.357 991.346
202106 919.170 107.579 1,015.455
202109 909.035 108.759 993.357
202112 853.472 109.676 924.841
202203 927.974 111.806 986.421
202206 900.939 114.083 938.569
202209 909.447 114.831 941.256
202212 938.404 115.200 968.116
202303 1,113.063 116.550 1,135.010
202306 1,143.997 117.140 1,160.676
202309 1,206.051 119.111 1,203.383
202312 1,300.194 118.848 1,300.194
202403 1,220.392 118.848 1,220.392

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Optus Pharmaceutical Co  (XKRX:131030) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Optus Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Optus Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Optus Pharmaceutical Co (XKRX:131030) Business Description

Traded in Other Exchanges
N/A
Address
50, Osongsaengmyeong-6-ro Osong-eub, Heungduk-gu Cheongju-si Chungcheongbuk-do, Mansu-li, KOR, 28158
Optus Pharmaceutical Co Ltd is engaged in the manufacturing of finished medicaments.

Optus Pharmaceutical Co (XKRX:131030) Headlines

No Headlines